These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1179 related items for PubMed ID: 26148052
21. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL. Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233 [Abstract] [Full Text] [Related]
22. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [Abstract] [Full Text] [Related]
23. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors. Stolz M, Tinguely C, Fontana S, Niederhauser C. Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974 [Abstract] [Full Text] [Related]
24. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. Twagirumugabe T, Swaibu G, Walker TD, Lindh M, Gahutu JB, Bergström T, Norder H. BMC Infect Dis; 2017 Jan 06; 17(1):32. PubMed ID: 28056881 [Abstract] [Full Text] [Related]
25. Occult hepatitis B virus infection with positive hepatitis B e antigen. Han Z, Liu Y, Pan J, Bi Y, Liu J, Zhou YH. Clin Chim Acta; 2015 Jan 01; 438():266-8. PubMed ID: 25218700 [Abstract] [Full Text] [Related]
26. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Muselmani W, Habbal W, Monem F. Transfus Med; 2013 Aug 01; 23(4):265-8. PubMed ID: 23621787 [Abstract] [Full Text] [Related]
27. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature. Hedayati-Moghaddam MR, Tehranian F, Mosavat A, Miri R, Ahmadi Ghezeldasht S. Arch Iran Med; 2024 Jun 01; 27(6):305-312. PubMed ID: 38855800 [Abstract] [Full Text] [Related]
28. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. Tandoi F, Caviglia GP, Pittaluga F, Abate ML, Smedile A, Romagnoli R, Salizzoni M. Dig Liver Dis; 2014 Nov 01; 46(11):1020-4. PubMed ID: 25201211 [Abstract] [Full Text] [Related]
29. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile. Vargas JI, Jensen D, Sarmiento V, Peirano F, Acuña P, Fuster F, Soto S, Ahumada R, Huilcaman M, Bruna M, Jensen W, Fuster F. J Med Virol; 2016 Apr 01; 88(4):639-46. PubMed ID: 26381185 [Abstract] [Full Text] [Related]
30. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ. Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 01; 21(3):189-91. PubMed ID: 23967739 [Abstract] [Full Text] [Related]
31. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. Almeida RP, Cardoso DD. J Clin Virol; 2006 Jul 01; 36(3):231-4. PubMed ID: 16574475 [Abstract] [Full Text] [Related]
32. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Hum Antibodies; 2011 Jul 01; 20(3-4):77-82. PubMed ID: 22129677 [Abstract] [Full Text] [Related]
33. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. J Infect; 2005 Jul 01; 51(1):24-9. PubMed ID: 15979486 [Abstract] [Full Text] [Related]
34. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Blood Transfus; 2019 Nov 01; 17(6):403-408. PubMed ID: 31846605 [Abstract] [Full Text] [Related]
35. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb 01; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
36. Infectivity of blood products from donors with occult hepatitis B virus infection. Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshøj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L, Ullum H, Candotti D, Lelie N, Gerlich WH, Chudy M. Transfusion; 2013 Jul 01; 53(7):1405-15. PubMed ID: 23362802 [Abstract] [Full Text] [Related]
37. Occult Hepatitis B Infection Among Blood Donors in Al Azhar University Hospital, Upper Egypt: The Current Status After 25 years of Vaccine Introduction. Mahmoud AI, Elsherbiny NM, Afifi NA, Ahmed BM, Yasin AS. Egypt J Immunol; 2018 Jan 01; 25(1):45-56. PubMed ID: 30242997 [Abstract] [Full Text] [Related]
38. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. Altunay H, Kosan E, Birinci I, Aksoy A, Kirali K, Saribas S, Aslan M, Yuksel P, Alan E, Yenen OS, Kocazeybek B. Transfus Apher Sci; 2010 Dec 01; 43(3):265-268. PubMed ID: 20934912 [Abstract] [Full Text] [Related]
39. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR, SIMTI study group for HBV infection among first-time blood donors. Blood Transfus; 2013 Apr 01; 11(2):281-8. PubMed ID: 23399361 [Abstract] [Full Text] [Related]